Home Search

epipen shortage - search results

If you're not happy with the results, please do another search
EpiPen and Generic

Epipen Supply Status Update and Extension of Expiration Dates

Tighter supplies and greater variability in pharmacy-level access will potentially continue through the summer months as seasonal demand increases.
Heather Bresch Testifying Before House Oversight Committee

As EpiPen Company's Stock Plummets, CEO Heather Bresch Gets A Raise

0
You would think the CEO of a company whose stock lost 63% of its value would be shown the door. You would be wrong.
EpiPen Shortage

EpiPen Manufacturer Under Civil Investigation by US Attorney

0
The company disclosed it was responding to an investigation of quality issues at the facility.
Teva Epinephrine Auto-Injector Two-Pack

Teva's EpiPen Generic in Short Supply as US Launch Stalls

0
Where is the device that would help alleviate the auto-injector shortage?
Teva Generic

Teva Launches EpiPen Generic in US Priced at $300

0
Adult dose device available now in limited quantities with "Jr" dose available in the new year.
Sen Blumenthal with EpiPen

Senator to Introduce the 'Cure High Drug Prices Act' Spurred On by EpiPen Costs

0
“We’re talking about a workhorse drug. It is a matter of life and death for kids when they have emergency reactions."
Half-Staff

Editorial: Epinephrine Auto-Injector Shortage? So What if a Few Kids Die!

0
Look around and see our healthcare institutions failing to keep us safe. Meanwhile, we are failing our kids.
EpiPens

Pfizer Issues Statement Extending the Expiration Date for Select Lots of EpiPen

To address shortages of EpiPen, Pfizer is coordinating with FDA to extend the expiration dates of specific lots of EpiPen® 0.3 mg Auto-Injectors.
Vibex Auto-Injector from Teva partner Antares

FDA Approves First Generic Version of EpiPen

The FDA today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector.
For Sale by Owner

Did EpiPen Marketer Mylan Just Put Out Their 'For Sale' Sign?

0
Beset by turmoil in the generics market, Mylan considers its options.